Delivery Order SPE2DB20D9331-SPE2DB25FL1Y5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for LENVIMA 8 mg daily dose tablets (60-count supply) with a ceiling value of $11,353.77. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of September 19, 2025, represents a procurement of a specialized oncology medication. The contract carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 18 mg daily dose medication in a 90-day supply. The contract, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,353.77 by the Defense Logistics Agency on August 22, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count). This firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance taking place at the vendor's Park Ridge location. The award was made without a set-aside designation, reflecting...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,006.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a prescription medication, with a period of performance through August 5, 2024. This delivery order contract was issued under DMS Pharmaceutical Group's existing, single-award indefinite delivery contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency on September 9, 2025, for the supply of Lenvima 10 mg daily dose tablets (30-count packaging). The contract carries an ultimate completion date of September 30, 2025, and includes no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 10 mg daily dose tablets (30-count packaging). This firm fixed-price delivery order was issued on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing this work from its Park Ridge...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency for the supply of Lenvima 14 mg daily dose medication in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, is scheduled for completion by October 1, 2025, with no set-aside designation applied. The award represents a continuation of DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $22,013.90, is for the delivery of 4565030359 - LENVIMA 18 MG DAILY DOSE 90S, with a completion date of July 19, 2024. This award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...
- The U.S. Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. for LENVIMA 20 mg daily dose (60-count supply) valued at $11,353.77 on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was awarded without set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 firm fixed-price delivery order is for the supply of Lenvima 12 mg daily dose 90 tablets. It is issued under a larger DLA Indefinite Delivery Contract (IDC), valued at $499,999,999, that enables the DLA to place delivery orders for a comprehensive range of pharmaceutical products to support...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1Y5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 8 mg daily dose tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025. The contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal pharmaceutical procurement market. Performance will occur at the vendor's facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group leverages this master contract to fulfill specific medication requirements for military health systems, with Lenvima—an oncology treatment—representing one of many specialized pharmaceutical products the company distributes to government healthcare providers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 9/10/25 |